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EDITORIAL COMMENTARYExamining the face of aortic dissection outside the Western worldJohn A. Elefteriades, MD,a and Bulat A. Ziganshin, MDa,bSee related article on pages 2995-3000.Aortic dissection is a challenging foe, having earned a
well-deserved reputation as the great masquerader by virtue
of the fact that its presentation canmimic awide range of dis-
eases. Dissection can present as myocardial infarction,
stroke, paraplegia, leg ischemia, renal failure, and
abdominal catastrophe—reflecting the fact that dissection
can disrupt blood flow to any organ in the body (see
Figure 1). As challenging as aortic dissection can be to
recognize and treat, we have largely experienced the
behavior of this disease only in the West. Variations around
theworldmay contribute to even greater complexity thanwe
have appreciated. Genetic, environmental, and social factors
may produce differences in behavior of aortic dissection in
other environments. The study by Wang and colleagues1
gives us a look at the face of acute aortic dissection in China.
Specifically, Wang and colleagues1 describe their new
Registry of Aortic Dissection in China (Sino-RAD), which
currently includes>1000 patients presenting acutely to 15
different centers across the country during a 2-year period.
The authors provide a descriptive report of the patients
included in Sino-RAD as well as a statistical comparison
of clinical characteristics with the International Registry
of Acute Aortic Dissection (IRAD). Establishing this
nationwide database is a major accomplishment, and the
authors are to be congratulated on this achievement as
well as on their well-written report. This new information
from China supplements the important work previously
reported by Sun and colleagues2 describing their single-
center experience treating >450 acute type A aortic
dissection patients in Beijing.
Compared with IRAD (which represents aortic dissection
patterns predominantly in Western countries), Sino-RAD,
representative solely of Chinese patients with aortic
dissection, reveals several distinctive features of this disease
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 Substantial male predominance, and
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Sun and colleagues2 also found presentation at a young
age (mean age, 46.2 years) and male preponderance
(82.5%). However the experience of Sun and colleagues2
does not confirm a low incidence of hypertension (73%
hypertension, similar to the IRAD findings [67%], but
contrary to the Sino-RAD data [51%]).
Several other observations in the article by Wang and
colleagues1 deserve comment.
The authors1 show a significantly lower in-hospital
mortality for Sino-RAD patients compared with patients
included in IRAD (10.3% vs 27.4%). This comparison
should be taken with a grain of salt. First, Sino-RAD data
are being compared with IRAD data that were published 14
years ago. Significant improvements in diagnosis and
treatment modalities have been made since that time.
Second, aswe know fromour collaborationwith Sun and col-
leagues,2 there is a certain natural selection that takes place in
China: the sickest patients with an aortic dissection may not
make it to hospital due to a lack of resources and/or large
travel distances involved. Therefore, patients who do make
it to hospital in China may already be self-selected for
survival. This is in contrast to the experience inWestern coun-
tries, where this access impediment is likely less prominent.
Another characteristic that stands out is the unusually
high use of endovascular therapy in patients with acute
type B dissection—almost 70% received a stent graft.
Although endovascular therapy for type B aortic dissection
is being increasingly investigated, we believe that such
widespread application may be premature. We remain to
be convinced that routine stent grafting for type B
dissection produces substantial benefit above and beyond
the complication-specific approach that we articulated
nearly 25 years ago.3 The vast majority of type B dissection
patients have a benign early and late course. A recent study
by our group (unpublished data) confirms our original
findings of good early survival (87%), good late survival
(51% at 10 years), slow growth rate (0.2 cm/y), and low
need for late surgical intervention (67% freedom from
surgery at 10 years) with medical management in a
complication-specific approach. Of course, there may be
exigencies specific to China (such as poor compliance
with follow-up regimens) that make early interventional
therapy more appropriate than in Western environments.
The greatest potential of the Sino-RAD database will be
found in realization of long-term follow-up. Wang and
colleagues1 provide data on the in-hospital course only.
The Chinese database will become immensely usefuldiovascular Surgery c Volume 148, Number 6 3001
FIGURE 1. Schematic representation of various conditions that can bemimickedby aortic dissection. (Reprintedwith permission fromElefteriades JA, Tribble
C, Geha AS, Siegel M, Cohen LS. House officer’s guide to ICU care: fundamentals of management of the heart and lungs. Minneapolis: CardioText; 2012.)
Editorial Commentary Elefteriades and Ziganshinwhen long-term clinical and radiologic follow-up have been
accomplished.
Wang and colleagues1 tell us that they set out to improve
the diagnosis and treatment of acute dissection in China.
Establishing this Sino-RAD database is a very meaningful
first step. However, they fall short of clearly identifying
how the current information will accomplish improvement
in the diagnosis and treatment of patients with aortic
dissection in China. We look forward to substantial clinical
insights as this important work is taken forward.
Whether the Western/Chinese differences identified in
the work by Wang and colleagues1 are related to genetic,
environmental, or social factors remains to be determined.
It is likely that genetic contributions to ethnic differences
in behavior of aortic dissection will be clarified in the3002 The Journal of Thoracic and Cardiovascular Surrelatively near future, because whole exome sequencing is
now being performed routinely at select centers in patients
with thoracic aortic aneurysm and dissection.4References
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